European thromboprophylaxis practice amongst paediatric cardiology units
• This study outlines the variation in practice amongst clinicians in Europe in the indications for thromboprophylaxis, medications used and duration of treatment for both congenital and acquired heart disease in paediatric patients. • This study highlights the need for up-to-date, evidence-based thromboprophylaxis guidelines for this patient population, including recommendations on direct oral anticoagulant use.
Authors
- Estelle Naumburg (ORCID: https://orcid.org/0000-0001-6090-494X)
- Michal Odermarsky (ORCID: https://orcid.org/0000-0002-0852-5691)
- Sean T Kelleher (ORCID: https://orcid.org/0000-0002-3021-5462)
- Damien Bonnet (ORCID: https://orcid.org/0000-0002-8722-5805)
- Daniël De Wolf (ORCID: https://orcid.org/0000-0002-0846-8914)
- Ciara Ryan (ORCID: https://orcid.org/0000-0002-6070-4240)
- Christoph Male (ORCID: https://orcid.org/0000-0002-4989-6421)
- Willem A. Helbing (ORCID: https://orcid.org/0000-0002-1023-1537)
- Zdenka Reinhardt (ORCID: https://orcid.org/0000-0002-4446-1138)
- Colin J. McMahon
Institutions
- Hôpital Necker-Enfants Malades (FR)
- Lund University (SE)
- Université Paris Cité (FR)
- Ghent University Hospital (BE)
- Freeman Hospital (GB)
- Assistance Publique – Hôpitaux de Paris (FR)
- Skåne University Hospital (SE)
- Medical University of Vienna (AT)
- Umeå University (SE)
Publication Details
- Journal
- European Journal of Pediatrics
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1007/s00431-025-06351-x
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University College Dublin